Purdue Pharma’s $7 billion-plus opioid settlement plan is set for voting by local governments and affected individuals after a judge deemed the information sufficient. The settlement, aimed at resolving thousands of lawsuits and preventing trials over $2 trillion in claims, could be one of the largest in opioid litigation history. If approved, funds will support addiction treatment and victims, with a hearing scheduled for November.
